APO Research
Talk to an analyst

APO RESEARCH · REPORT

C5a Anaphylatoxin Chemotactic Receptor 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global C5a Anaphylatoxin Chemotactic Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025179 pages

Choose your research edition.

Industry ResearchC5a Anaphylatoxin Chemotactic Receptor 1 Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal C5a Anaphylatoxin Chemotactic Receptor 1 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global C5a Anaphylatoxin Chemotactic Receptor 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C5a Anaphylatoxin Chemotactic Receptor 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C5a Anaphylatoxin Chemotactic Receptor 1 include AFFiRiS AG, ChemoCentryx, Inc., Dompe Farmaceutici S.p.A. and Noxxon Pharma AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C5a Anaphylatoxin Chemotactic Receptor 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C5a Anaphylatoxin Chemotactic Receptor 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C5a Anaphylatoxin Chemotactic Receptor 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C5a Anaphylatoxin Chemotactic Receptor 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Company

AFFiRiS AG

ChemoCentryx, Inc.

Dompe Farmaceutici S.p.A.

Noxxon Pharma AG

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Type

NOXD-20

NOXD-19

EP-67

DF-2593A

Others

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Application

Allergic Asthma

Huntington Disease

Acute Pain

Kidney Disease

Others

C5a Anaphylatoxin Chemotactic Receptor 1 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C5a Anaphylatoxin Chemotactic Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C5a Anaphylatoxin Chemotactic Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C5a Anaphylatoxin Chemotactic Receptor 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C5a Anaphylatoxin Chemotactic Receptor 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C5a Anaphylatoxin Chemotactic Receptor 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of C5a Anaphylatoxin Chemotactic Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of C5a Anaphylatoxin Chemotactic Receptor 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Trends Table 2. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Drivers Table 3. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Opportunities and Challenges Table 4. C5a Anaphylatoxin Chemotactic Receptor 1 Industry Restraints Table 5. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Manufacturers Table 9. Global C5a Anaphylatoxin Chemotactic Receptor 1 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global C5a Anaphylatoxin Chemotactic Receptor 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global C5a Anaphylatoxin Chemotactic Receptor 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global C5a Anaphylatoxin Chemotactic Receptor 1 Manufacturers, Product Type & Application Table 13. Global C5a Anaphylatoxin Chemotactic Receptor 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global C5a Anaphylatoxin Chemotactic Receptor 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of NOXD-20 Table 17. Major Manufacturers of NOXD-19 Table 18. Major Manufacturers of EP-67 Table 19. Major Manufacturers of DF-2593A Table 20. Major Manufacturers of Others Table 21. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type (2021-2026) & (W Units) Table 23. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type (2027-2032) & (W Units) Table 24. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Type (2021-2026) Table 25. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Type (2027-2032) Table 26. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type (2021-2026) & (W Units) Table 28. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type (2027-2032) & (W Units) Table 29. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Type (2021-2026) Table 30. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Allergic Asthma Table 32. Major Manufacturers of Huntington Disease Table 33. Major Manufacturers of Acute Pain Table 34. Major Manufacturers of Kidney Disease Table 35. Major Manufacturers of Others Table 36. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application (2021-2026) & (W Units) Table 38. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application (2027-2032) & (W Units) Table 39. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Application (2021-2026) Table 40. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Application (2027-2032) Table 41. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application (2021-2026) & (W Units) Table 43. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application (2027-2032) & (W Units) Table 44. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Application (2021-2026) Table 45. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Application (2027-2032) Table 46. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2021-2026) & (W Units) Table 48. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Region (2021-2026) Table 49. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026) & (W Units) Table 53. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032) & (W Units) Table 54. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026) & (W Units) Table 56. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2027-2032) & (W Units) Table 63. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Region (2021-2026) Table 67. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Region (2027-2032) Table 68. AFFiRiS AG Company Information Table 69. AFFiRiS AG Business Overview Table 70. AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 72. AFFiRiS AG Recent Development Table 73. ChemoCentryx, Inc. Company Information Table 74. ChemoCentryx, Inc. Business Overview Table 75. ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 77. ChemoCentryx, Inc. Recent Development Table 78. Dompe Farmaceutici S.p.A. Company Information Table 79. Dompe Farmaceutici S.p.A. Business Overview Table 80. Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 82. Dompe Farmaceutici S.p.A. Recent Development Table 83. Noxxon Pharma AG Company Information Table 84. Noxxon Pharma AG Business Overview Table 85. Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio Table 87. Noxxon Pharma AG Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. C5a Anaphylatoxin Chemotactic Receptor 1 Distributors List Table 91. C5a Anaphylatoxin Chemotactic Receptor 1 Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. C5a Anaphylatoxin Chemotactic Receptor 1 Product Image Figure 2. Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales (2021-2032) & (W Units) Figure 5. Global C5a Anaphylatoxin Chemotactic Receptor 1 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 C5a Anaphylatoxin Chemotactic Receptor 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. NOXD-20 Image Figure 9. NOXD-19 Image Figure 10. EP-67 Image Figure 11. DF-2593A Image Figure 12. Others Image Figure 13. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Type (2021-2032) Figure 16. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Type (2021-2032) Figure 19. Allergic Asthma Image Figure 20. Huntington Disease Image Figure 21. Acute Pain Image Figure 22. Kidney Disease Image Figure 23. Others Image Figure 24. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Application (2021-2032) Figure 27. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Application (2021-2032) Figure 30. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2021-2032) Figure 32. U.S. C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2021-2032) Figure 37. Germany C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2021-2032) Figure 44. China C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Country (2021-2032) Figure 52. Brazil C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile C5a Anaphylatoxin Chemotactic Receptor 1 Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032) & (US$ Million) Figure 63. North America C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032) & (US$ Million) Figure 65. Europe C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. C5a Anaphylatoxin Chemotactic Receptor 1 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. C5a Anaphylatoxin Chemotactic Receptor 1 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • NOXD-20
  • NOXD-19
  • EP-67
  • DF-2593A
  • Others
Applications
  • Allergic Asthma
  • Huntington Disease
  • Acute Pain
  • Kidney Disease
  • Others
Companies covered
  • AFFiRiS AG
  • ChemoCentryx, Inc.
  • Dompe Farmaceutici S.p.A.
  • Noxxon Pharma AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market Dynamics
  1. 2.1 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Trends
  2. 2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Drivers
  3. 2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Opportunities and Challenges
  4. 2.4 C5a Anaphylatoxin Chemotactic Receptor 1 Industry Restraints
3 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Manufacturers
  1. 3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C5a Anaphylatoxin Chemotactic Receptor 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global C5a Anaphylatoxin Chemotactic Receptor 1 Manufacturers, Product Type & Application
  7. 3.7 Global C5a Anaphylatoxin Chemotactic Receptor 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C5a Anaphylatoxin Chemotactic Receptor 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C5a Anaphylatoxin Chemotactic Receptor 1 Tier 1, Tier 2, and Tier 3
4 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Type
  1. 4.1 C5a Anaphylatoxin Chemotactic Receptor 1 Type Introduction
  2. 4.1.1 NOXD-20
  3. 4.1.2 NOXD-19
  4. 4.1.3 EP-67
  5. 4.1.4 DF-2593A
  6. 4.1.5 Others
  7. 4.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type
  8. 4.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Type (2021-2032)
  10. 4.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Type (2021-2032)
  11. 4.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type
  12. 4.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Type (2021-2032)
  14. 4.3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Type (2021-2032)
5 C5a Anaphylatoxin Chemotactic Receptor 1 Market by Application
  1. 5.1 C5a Anaphylatoxin Chemotactic Receptor 1 Application Introduction
  2. 5.1.1 Allergic Asthma
  3. 5.1.2 Huntington Disease
  4. 5.1.3 Acute Pain
  5. 5.1.4 Kidney Disease
  6. 5.1.5 Others
  7. 5.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application
  8. 5.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Application (2021-2032)
  10. 5.2.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Market Share by Application (2021-2032)
  11. 5.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application
  12. 5.3.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Application (2021-2032)
  14. 5.3.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Application (2021-2032)
6 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region
  1. 6.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2021-2032)
  3. 6.2.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Region (2021-2026)
  4. 6.2.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region
  1. 7.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region
  2. 7.1.1 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032)
  8. 7.2.2 North America C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032)
  11. 7.3.2 Europe C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa C5a Anaphylatoxin Chemotactic Receptor 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AFFiRiS AG
  2. 8.1.1 AFFiRiS AG Company Information
  3. 8.1.2 AFFiRiS AG Business Overview
  4. 8.1.3 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AFFiRiS AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  6. 8.1.5 AFFiRiS AG Recent Developments
  7. 8.2 ChemoCentryx, Inc.
  8. 8.2.1 ChemoCentryx, Inc. Company Information
  9. 8.2.2 ChemoCentryx, Inc. Business Overview
  10. 8.2.3 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ChemoCentryx, Inc. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  12. 8.2.5 ChemoCentryx, Inc. Recent Developments
  13. 8.3 Dompe Farmaceutici S.p.A.
  14. 8.3.1 Dompe Farmaceutici S.p.A. Company Information
  15. 8.3.2 Dompe Farmaceutici S.p.A. Business Overview
  16. 8.3.3 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dompe Farmaceutici S.p.A. C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  18. 8.3.5 Dompe Farmaceutici S.p.A. Recent Developments
  19. 8.4 Noxxon Pharma AG
  20. 8.4.1 Noxxon Pharma AG Company Information
  21. 8.4.2 Noxxon Pharma AG Business Overview
  22. 8.4.3 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Noxxon Pharma AG C5a Anaphylatoxin Chemotactic Receptor 1 Product Portfolio
  24. 8.4.5 Noxxon Pharma AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C5a Anaphylatoxin Chemotactic Receptor 1 Value Chain Analysis
  2. 9.1.1 C5a Anaphylatoxin Chemotactic Receptor 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C5a Anaphylatoxin Chemotactic Receptor 1 Production Mode & Process
  6. 9.2 C5a Anaphylatoxin Chemotactic Receptor 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C5a Anaphylatoxin Chemotactic Receptor 1 Distributors
  9. 9.2.3 C5a Anaphylatoxin Chemotactic Receptor 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst